FDA Import Refusal F23-9340161-7/50002/1 — Boehringer Ingelheim Hellas A.E.
The FDA refused shipment F23-9340161-7/50002/1 from Boehringer Ingelheim Hellas A.E. (Greece) on September 3, 2025. The refused product falls under Drugs and Biologics — EMPAGLIFLOZIN (ANTI-DIABETIC). Cited charge: 75 This firm has 1 other import refusal on record.
Refusal Details
- Date
- September 3, 2025
- Country
- Greece
- Product Category
- Drugs and Biologics
- Product Code
- 61PCY73 EMPAGLIFLOZIN (ANTI-DIABETIC)
- Charges
- 75